Reseligo (Goserelin Alvogen) Vefjalyf í áfylltri sprautu 10,8 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

reseligo (goserelin alvogen) vefjalyf í áfylltri sprautu 10,8 mg

zentiva k.s.* - goserelinum acetat - vefjalyf í áfylltri sprautu - 10,8 mg

Reseligo (Goserelin Alvogen) Vefjalyf í áfylltri sprautu 3,6 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

reseligo (goserelin alvogen) vefjalyf í áfylltri sprautu 3,6 mg

alvogen ehf. - goserelinum acetat - vefjalyf í áfylltri sprautu - 3,6 mg

Zoladex Vefjalyf 10,8 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

zoladex vefjalyf 10,8 mg

astrazeneca ab - goserelinum acetat - vefjalyf - 10,8 mg

Zoladex Vefjalyf 3,6 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

zoladex vefjalyf 3,6 mg

astrazeneca ab - goserelinum acetat - vefjalyf - 3,6 mg

Busol Stungulyf, lausn 0,004 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

busol stungulyf, lausn 0,004 mg/ml

t.p. whelehan son & co. ltd. - buserelinum acetat - stungulyf, lausn - 0,004 mg/ml

Firmagon Evrópusambandið - íslenska - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degarelix - blöðruhálskirtli - innkirtla meðferð - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Camcevi Evrópusambandið - íslenska - EMA (European Medicines Agency)

camcevi

accord healthcare s.l.u. - leuprorelin mesilate - blöðruhálskirtli - innkirtla meðferð - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Astrozol Filmuhúðuð tafla 1 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

astrozol filmuhúðuð tafla 1 mg

williams & halls ehf - anastrozolum inn - filmuhúðuð tafla - 1 mg

Eligard Stungulyfsstofn og leysir, lausn 7,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

eligard stungulyfsstofn og leysir, lausn 7,5 mg

recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 7,5 mg

Eligard Stungulyfsstofn og leysir, lausn 45 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

eligard stungulyfsstofn og leysir, lausn 45 mg

recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 45 mg